RK
Rashid Kashif Conseiller Juridique
Board M
€533,896
▲ Purchases (4 ops.)
Insider track record Board Director Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Rashid Kashif, Conseiller Juridique. Director active across 1 company, notably NEVRO CORP. In total, 42 reports have been recorded. Split: 4 buys · 0 sell. Total volume traded: €534k. History available since 4 June 2021. The latest transaction was filed on 20 March 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations 42 total
● SVP, Corp Dev and CLO · Executives · 3 Apr 2025 · NEVRO CORP 477,738 shares Common Stock SEC:0000950170-25-050461:0
◆ SVP, Corp Dev and CLO · Executives · 20 Mar 2025 · NEVRO CORP 1,136 shares 0Common Stock SEC:0001444380-25-000052:0
● SVP, Corp Dev and CLO · Executives · 7 Mar 2025 · NEVRO CORP 1,758 shares @ US$5.77 0.5% of flow Common Stock SEC:0001444380-25-000039:0
◆ SVP, Corp Dev and CLO · Executives · 28 Feb 2025 · NEVRO CORP 742 shares 0Common Stock SEC:0001444380-25-000028:0
● SVP, Corp Dev and CLO · Executives · 4 Jan 2025 · NEVRO CORP 527 shares @ US$3.71 0.1% of flow Common Stock SEC:0001444380-25-000008:0
● SVP, Corp Dev and CLO · Executives · 7 Dec 2024 · NEVRO CORP 1,759 shares @ US$4.19 0.4% of flow Common Stock SEC:0001444380-24-000014:0
● SVP, Corp Dev and CLO · Executives · 28 Nov 2024 · NEVRO CORP 816 shares @ US$4.58 0.2% of flow Common Stock SEC:0001444380-24-000010:0
● SVP, Corp Dev and CLO · Executives · 4 Oct 2024 · NEVRO CORP 479 shares @ US$4.97 0.1% of flow Common Stock SEC:0001610717-24-000502:0
● SVP, Corp Dev and CLO · Executives · 7 Sept 2024 · NEVRO CORP 1,759 shares @ US$5.18 0.4% of flow Common Stock SEC:0001610717-24-000470:0
● SVP, Corp Dev and CLO · Executives · 28 Aug 2024 · NEVRO CORP 817 shares @ US$5.76 0.2% of flow Common Stock SEC:0001610717-24-000460:0
● SVP, Corp Dev and CLO · Executives · 4 Jul 2024 · NEVRO CORP 479 shares @ US$8.38 0.2% of flow Common Stock SEC:0001610717-24-000391:0
● SVP, Corp Dev and CLO · Executives · 7 Jun 2024 · NEVRO CORP 1,759 shares @ US$9.27 0.8% of flow Common Stock SEC:0001610717-24-000320:0
● SVP, Corp Dev and CLO · Executives · 28 May 2024 · NEVRO CORP 817 shares @ US$9.52 0.4% of flow Common Stock SEC:0001610717-24-000268:0
● SVP, Corp Dev and CLO · Executives · 4 Apr 2024 · NEVRO CORP 479 shares @ US$13.21 0.3% of flow Common Stock SEC:0001610717-24-000204:0
84,326 shares 0Common Stock SEC:0001610717-24-000147:0
743 shares 0Common Stock SEC:0001610717-24-000136:0
1,790 shares @ US$14.22 1.3% of flow Common Stock SEC:0001610717-24-000125:0
898 shares @ US$14.82 0.7% of flow Common Stock SEC:0001610717-24-000104:0
526 shares @ US$19.39 0.5% of flow Common Stock SEC:0001610717-24-000017:0
800 shares @ US$16.67 0.7% of flow Common Stock SEC:0001610717-23-000371:0
1,879 shares @ US$18.07 1.8% of flow Common Stock SEC:0001610717-23-000307:0
800 shares @ US$19.39 0.8% of flow Common Stock SEC:0001610717-23-000247:0
450 shares @ US$28.27 0.6% of flow Common Stock SEC:0001610717-23-000097:0
800 shares @ US$26.45 1.1% of flow Common Stock SEC:0001610717-23-000083:0
39,282 shares 0Common Stock SEC:0001567619-23-004752:0
25 of 42 declarations
Load more (17 remaining) About Rashid Kashif Kashif Rashid is the General Counsel of NEVRO CORP. In this role, he is responsible for managing the company's legal affairs, including regulatory compliance and litigation management. His legal expertise is essential in protecting the company's interests.